The Impact of Detectable ADAMTS13 Inhibitor on the Clinical
Presentation and Outcome of Patients with Immune Thrombotic
Thrombocytopenic Purpura (iTTP): Analysis Using the United
States Thrombotic Microangiopathy (USTMA) Clinical Registry

Meera Sridharan, MD, Ana G Antun, MD, Lisa Baumann Kreuziger, Assistant Professor. MD MS,
Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS,
Todd Clover, MD, Elizabeth Davis, Andrew Johnson, MD, Keith McCrae, MD, Ming Yeong Lim,
MBBChir,J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Ronald S Go, MD